Risks and uncertainties include, among other things, the uncertainties inherent in research and development, including the ability to meet anticipated clinical endpoints, commencement and/or completion dates for clinical trials, regulatory submission dates, regulatory approval dates and/or launch dates, as well as the possibility of unfavorable new clinical data and further analyses of existing clinical data
Diabetes Obes Metabolism 15:1527 Merchenthaler I, Lane M, Shughrue P (1999) Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system
Mean weight loss at 2 years was 9.4% with semaglutide versus 0.9% with placebo [5]
Asuno GLP-1 weight-loss gummies Asuno GLP-1 weight-loss gummies official product page screenshot Asuno launched in late 2025
However, if you experience persistent or severe symptoms, contact your GP, as these may require medical assessment